[BABY] Natus Medical Incorporated

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 35 Change: 1.4 (4.17%)
Ext. hours: Change: 0 (0%)

chart BABY

Refresh chart

Strongest Trends Summary For BABY

BABY is in the medium-term up 33% in 3 months. In the long-term down -9% in 1 year and up 340% in 25 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Natus Medical Incorporated provides newborn care and neurology healthcare products worldwide. It offers healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The company?s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and incubators to control the newborn?s environment; and software systems for managing and tracking disorders and diseases for public health laboratories. It provides ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners; and hearing screening supply products that are used with newborn hearing screening devices. The company also offers diagnost

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS1.13 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 3.56% Sales Growth - Q/Q-4.91% P/E30.97
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA7.73% ROE9.57% ROI
Current Ratio3.06 Quick Ratio2.48 Long Term Debt/Equity Debt Ratio0.2
Gross Margin60.45% Operating Margin13.85% Net Profit Margin9.54% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities600 K Cash From Investing Activities-13.48 M Cash From Operating Activities13.81 M Gross Profit53.61 M
Net Profit8.6 M Operating Profit13.35 M Total Assets443.74 M Total Current Assets218.24 M
Total Current Liabilities71.39 M Total Debt Total Liabilities85.17 M Total Revenue89.39 M
Technical Data
High 52 week37.6 Low 52 week23.83 Last close24.04 Last change0.88%
RSI33.08 Average true range0.6 Beta0.8 Volume1.09 M
Simple moving average 20 days-4.94% Simple moving average 50 days-10.06% Simple moving average 200 days-25%
Performance Data
Performance Week-5.28% Performance Month-9.11% Performance Quart-28.47% Performance Half-27.59%
Performance Year-34.05% Performance Year-to-date-29.36% Volatility daily2% Volatility weekly4.46%
Volatility monthly9.14% Volatility yearly31.67% Relative Volume414.44% Average Volume391.2 K
New High New Low

News

2019-09-18 11:10:00 | Else Nutrition Approved to Trade on the OTCQB Market

2019-08-21 12:27:26 | Else Nutrition Holdings Inc. Shareholder Update

2019-08-21 09:00:00 | Shareholders Update

2019-07-27 12:03:00 | Natus Medical Is All Grown Up

2019-07-25 22:35:41 | Edited Transcript of BABY earnings conference call or presentation 25-Jul-19 8:30pm GMT

2019-07-25 22:23:55 | Natus Medical Inc BABY Q2 2019 Earnings Call Transcript

2019-07-25 20:05:12 | Natus Medical BABY Q2 Earnings and Revenues Top Estimates

2019-07-25 16:22:50 | Natus Medical Announces Second Quarter 2019 Financial Results

2019-07-25 14:30:00 | Natus Medical, Inc. to Host Earnings Call

2019-07-25 12:30:00 | Natus Medical Announces NASDAQ Ticker Symbol Change to “NTUS”

2019-07-18 10:32:02 | Analysts Estimate Natus Medical BABY to Report a Decline in Earnings: What to Look Out for

2019-07-11 07:00:00 | Natus Medical to Hold 2019 Second Quarter Financial Results Conference Call on July 25th

2019-07-10 08:00:00 | Else Nutrition’s CEO Letter to Shareholders

2019-06-26 08:01:00 | A-Labs Closes a CAD 7.5 million Round of Finance for ELSE Nutrition on the Toronto Stock Exchange Ventures

2019-06-26 07:48:00 | Else Nutrition, Plant-based Food Startup, Receives Huge Welcome on the Toronto Stock Exchange

2019-06-10 08:08:05 | See what the IHS Markit Score report has to say about Natus Medical Inc.

2019-06-08 08:11:36 | See what the IHS Markit Score report has to say about Natus Medical Inc.

2019-06-04 08:06:59 | See what the IHS Markit Score report has to say about Natus Medical Inc.

2019-05-24 13:11:05 | If You Had Bought Natus Medical NASDAQ:BABY Stock A Year Ago, You'd Be Sitting On A 27% Loss, Today

2019-05-21 09:07:04 | See what the IHS Markit Score report has to say about Natus Medical Inc.

2019-05-17 07:00:00 | Natus to Present at William Blair 39th Annual Growth Stock Conference

2019-05-15 18:04:22 | Argo’s Tack Runs Danger of Losing the Longer Race

2019-05-06 22:02:00 | INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Natus Medical, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-05-06 20:23:00 | EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Natus Medical, Inc. – BABY

2019-05-06 16:30:00 | Update to Natus Medical First Quarter 2019 Financial Results

2019-05-02 15:20:35 | Here’s What Hedge Funds Think About Natus Medical Inc BABY

2019-04-29 12:56:00 | Natus Medical Continues Its Restructuring

2019-04-25 22:13:36 | Edited Transcript of BABY earnings conference call or presentation 25-Apr-19 8:30pm GMT

2019-04-25 19:36:01 | Natus Medical Inc BABY Q1 2019 Earnings Call Transcript

2019-04-25 17:07:26 | Natus Medical: 1Q Earnings Snapshot

2019-04-25 16:05:00 | Natus Medical Announces First Quarter 2019 Financial Results

2019-04-25 14:30:00 | Natus Medical Incorporated to Host Earnings Call

2019-04-18 10:33:02 | Analysts Estimate Natus Medical BABY to Report a Decline in Earnings: What to Look Out for

2019-04-11 16:15:00 | UPDATE – Natus Medical to Hold 2019 First Quarter Financial Results Conference Call on April 25th

2019-04-09 10:50:20 | See what the IHS Markit Score report has to say about Natus Medical Inc.

2019-04-08 16:30:00 | Natus Medical to Hold 2019 First Quarter Financial Results Conference Call on April 25th

2019-04-08 10:13:02 | Natus Medical to Divest Medix for Focusing on Core Business

2019-04-02 16:30:00 | Natus Announces Sale of Medix Business

2019-03-29 19:00:00 | Bragar Eagel & Squire, P.C. is Investigating Natus Medical Incorporated BABY on Behalf of Stockholders and Encourages BABY Investors to Contact the Firm

2019-03-28 08:06:01 | See what the IHS Markit Score report has to say about Natus Medical Inc.

2019-03-26 16:50:00 | NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm

2019-03-26 08:25:57 | See what the IHS Markit Score report has to say about Natus Medical Inc.

2019-03-25 14:48:00 | 1 Surprising Reason Alzheimer's Drugs Remain So Elusive

2019-03-20 17:13:00 | NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm

2019-03-19 09:50:17 | See what the IHS Markit Score report has to say about Natus Medical Inc.

2019-03-07 17:18:00 | NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm

2019-03-07 16:23:51 | 6 Low Price-Sales Stocks

2019-03-06 05:43:00 | Why Natus Medical Stock Dropped 18.1% in February

2019-03-05 08:08:14 | See what the IHS Markit Score report has to say about Natus Medical Inc.

2019-03-01 16:48:34 | Natus Medical Inc BABY Files 10-K for the Fiscal Year Ended on December 31, 2018